Skip to main content

Table 1 Pre-HAART characteristics of the study population.

From: Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen

Variables

 

NNRTI

PI

p value

  

n = 43

N = 44

 

25-(OH)D (ng/ml)

mean ± SD

26.6 ± 13.5

22.6 ± 8.9

0.101

Sex Male

n (%)

38 (88.4)

34 (77.3)

0.256

Dark skin color

n (%)

7 (16.3)

10 (22.7)

0.590

Pre-HAART sampling

    

   Winter

n (%)

15 (34.9)

17 (38.6)

0.657

   Spring

n (%)

5 (11.6)

8 (18.2)

 

   Summer

n (%)

11 (25.6)

11 (25.0)

 

   Fall

n (%)

12 (27.9)

8 (18.2)

 

Age (years)

median (IQR)

38.6 (30.8;44.8)

37 (31.8;44.6)

0.929

Weight (Kg)α

median (IQR)

73 (68;85)

70.5 (65.3;83.5)

0.675

CD4 (cells/mm3)

    

   Nadir

median (IQR)

224 (181;292)

247.5 (182;314.5)

0.61

   pre-HAART

median (IQR)

254 (183;338)

299 (241;390.5)

0.052

Viral Load (log10)

median (IQR)

5.24 (4.95;5.53)

5.5 (4.97;5.86)

0.168

HIV stage (CDC)

    

   A

n (%)

31 (72.1)

32 (72.7)

0.640

   B

n (%)

8 (18.6)

6 (13.6)

 

   C

n (%)

4 (9.3)

6 (13.6)

 
  1. PI: Protease inhibitors; NNRTI: non-nucleoside reverse transcriptase inhibitors; SD: Standard deviation; IQR: Interquartile range; α n = 85